-
My Account
In App
My Account
BSE Live
Mar 28, 15:40Prev. Close
3.21
Open Price
3.26
Bid Price (Qty.)
3.10 (100)
Offer Price (Qty.)
3.26 (1000)
NSE Live
Mar 28, 15:31Prev. Close
3.30
Open Price
3.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Sharon Bio Medicine (in Rs. Cr.) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 1.15 | 1.15 | 1.15 | 23.79 | 23.79 | |
| Total Share Capital | 1.15 | 1.15 | 1.15 | 23.79 | 23.79 | |
| Reserves and Surplus | -591.50 | -610.37 | -626.62 | -663.54 | -648.25 | |
| Total Reserves and Surplus | -591.50 | -610.37 | -626.62 | -663.54 | -648.25 | |
| Total Shareholders Funds | -590.34 | -609.22 | -625.47 | -639.75 | -624.47 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 558.02 | 558.02 | 558.02 | 558.02 | 558.02 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.40 | 1.13 | 1.75 | 2.68 | |
| Long Term Provisions | 6.29 | 7.07 | 5.38 | 3.43 | 0.00 | |
| Total Non-Current Liabilities | 564.31 | 565.48 | 564.53 | 563.20 | 560.69 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 269.31 | 269.31 | 269.31 | 269.31 | 269.31 | |
| Trade Payables | 40.88 | 43.46 | 43.15 | 49.30 | 46.20 | |
| Other Current Liabilities | 26.33 | 28.81 | 37.92 | 33.61 | 15.68 | |
| Short Term Provisions | 2.56 | 1.29 | 0.77 | 0.65 | 0.55 | |
| Total Current Liabilities | 339.08 | 342.87 | 351.15 | 352.87 | 331.74 | |
| Total Capital And Liabilities | 313.04 | 299.14 | 290.21 | 276.32 | 267.97 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 128.13 | 134.79 | 141.49 | 148.68 | 181.51 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 128.13 | 134.79 | 141.49 | 148.68 | 181.51 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.77 | 0.63 | 1.28 | 0.00 | |
| Other Non-Current Assets | 9.10 | 8.70 | 8.63 | 7.40 | 7.40 | |
| Total Non-Current Assets | 137.23 | 144.26 | 150.74 | 157.36 | 188.91 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 39.02 | 42.33 | 49.32 | 40.00 | 28.48 | |
| Trade Receivables | 26.08 | 26.88 | 29.28 | 22.17 | 20.41 | |
| Cash And Cash Equivalents | 89.99 | 51.63 | 31.89 | 31.61 | 3.56 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 1.26 | |
| OtherCurrentAssets | 20.72 | 34.04 | 28.98 | 25.18 | 25.34 | |
| Total Current Assets | 175.82 | 154.87 | 139.46 | 118.96 | 79.06 | |
| Total Assets | 313.04 | 299.14 | 290.21 | 276.32 | 267.97 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
31.05.2023
Sharon Bio Medi Standalone March 2023 Net Sales at Rs 44.24 crore, down 11.12% Y-o-Y
12.02.2023
Sharon Bio Medi Standalone December 2022 Net Sales at Rs 57.74 crore, up 30.19% Y-o-Y
18.05.2022
Sharon Bio Medi Standalone March 2022 Net Sales at Rs 49.77 crore, up 2.47% Y-o-Y
07.02.2022
Sharon Bio Medi Standalone December 2021 Net Sales at Rs 44.35 crore, down 1.95% Y-o-Y
31.05.2023
Sharon Bio Medi Standalone March 2023 Net Sales at Rs 44.24 crore, down 11.12% Y-o-Y
12.02.2023
Sharon Bio Medi Standalone December 2022 Net Sales at Rs 57.74 crore, up 30.19% Y-o-Y
18.05.2022
Sharon Bio Medi Standalone March 2022 Net Sales at Rs 49.77 crore, up 2.47% Y-o-Y
07.02.2022
Sharon Bio Medi Standalone December 2021 Net Sales at Rs 44.35 crore, down 1.95% Y-o-Y
